https://scholars.lib.ntu.edu.tw/handle/123456789/413592
標題: | Comparison of the metabolic effects of metformin and troglitazone on fructose-induced insulin resistance in male sprague-dawley rats | 作者: | Chen C.-C. Wang H.-J. Shih H.-C. Sheen L.-Y. Chang C.-T. Chen R.-H. Wang T.-Y. |
關鍵字: | Hyperinsulinemia;Insulin resistance;Leptin;Metformin;Rat;Troglitazone | 公開日期: | 2001 | 卷: | 100 | 期: | 3 | 起(迄)頁: | 176-180 | 來源出版物: | Journal of the Formosan Medical Association | 摘要: | Background and purpose: Insulin resistance is a hallmark of the development of type 2 diabetes. Metformin and troglitazone are oral antidiabetic agents used to reduce insulin resistance. The aim of this study was to compare the metabolic effects of these two drugs in fructose-induced insulin-resistant rodents. Methods: Male Sprague-Dawley rats were allocated to receive one of the following four treatments for 6 weeks: normal rat chow (control group, n = 7), high-fructose diet (fructose group, n = 7), high-fructose diet plus metformin (metformin group, n = 8), or high-fructose diet plus troglitazone (troglitazone group, n = 8). Systolic blood pressure (SBP), insulin, free fatty acid (FFA), and triglyceride concentrations were measured as parameters of insulin resistance. Leptin concentration was also measured in the four groups. Results: The fructose group developed significantly elevated SBP, hyperinsulinemia, and hypertriglyceridemia without significant change in body weight or leptin concentration compared with the control group. The metformin group had significantly reduced body weight (397.9 ¡? 40.9 vs 470.1 ¡? 59.6 g, p < 0.05), insulin concentration (14.8 ¡? 10.5 vs 48.4 ¡? 15.2 £gU/mL, p < 0.05), triglyceride concentration (75.3 ¡? 65.5 vs 250.1 ¡? 95.7 mg/dL, p < 0.05), and leptin concentration (3.1 ¡? 1.5 vs 6.9 ¡? 2.0 ng/mL, p < 0.05) without significant change in SBP (147.8 ¡? 5.8 vs 152.4 ¡? 13.0 mm Hg, p > 0.05) compared with the fructose group. The troglitazone group had significantly reduced SBP (137.8 ¡? 9.2 vs 15.24 ¡? 13.0 mm Hg, p < 0.05), insulin concentration (15.0 ¡? 13.6 vs 48.4 ¡? 15.2 £gU/mL, p < 0.05), FFA concentration (38.9 ¡? 22.7 vs 78.7 ¡? 24.6 mg/dL, p < 0.05), triglyceride concentration (67.6 ¡? 32.4 vs 250.1 ¡? 95.7 mg/dL, p < 0.05), and leptin concentration (4.4 ¡? 2.0 vs 6.9 ¡? 2.0 ng/mL, p < 0.05) without significant change in body weight (452.5 ¡? 32.8 vs 470.1 ¡? 59.6 g, p > 0.05) compared with the fructose group. The metabolic effects of metformin and troglitazone on insulin, FFA, triglyceride, and leptin concentrations were not significantly different. However, metformin treatment resulted in significantly lower body weight (397.9 ¡? 40.9 vs 452.5 ¡? 32.8 g) and troglitazone treatment in significantly lower SBP (137.8 ¡? 9.2 vs 147.8 ¡? 5.8 mm Hg) compared to the fructose group, after adjusting for basal values (p < 0.05). Conclusions: Both metformin and troglitazone were comparably effective in reducing insulin resistance. Metformin treatment caused body weight reduction but was not effective in reducing SBP. Troglitazone treatment lowered SBP but did not reduce body weight. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/413592 | ISSN: | 9296646 |
顯示於: | 食品科技研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。